Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
896
archived clinical trials in
Gastroesophageal Reflux Disease

YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Rejendra Prasad Gupta
mi
from
Trenton, NJ
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Rejendra Prasad Gupta
mi
from
Trenton, NJ
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Vitaly Fishbein
mi
from
West Orange, NJ
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Vitaly Fishbein
mi
from
West Orange, NJ
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Wieslaw Ignatowicz
mi
from
Brooklyn, NY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Wieslaw Ignatowicz
mi
from
Brooklyn, NY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Eugene Bonapace
mi
from
Great Neck, NY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Eugene Bonapace
mi
from
Great Neck, NY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. James Grendell
mi
from
Mineola, NY
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. James Grendell
mi
from
Mineola, NY
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. William Harlan
mi
from
Asheville, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. William Harlan
mi
from
Asheville, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. John Poulos
mi
from
Fayetteville, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. John Poulos
mi
from
Fayetteville, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Peter Eweje
mi
from
Jacksonville, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Peter Eweje
mi
from
Jacksonville, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Charles Barish
mi
from
Raleigh, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Charles Barish
mi
from
Raleigh, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. William Gramley
mi
from
Wilmington, NC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. William Gramley
mi
from
Wilmington, NC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Robert Kindel
mi
from
Cincinnati, OH
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Robert Kindel
mi
from
Cincinnati, OH
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Gregory Cooper
mi
from
Cleveland, OH
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Gregory Cooper
mi
from
Cleveland, OH
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Gary Falk
mi
from
Cleveland, OH
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Gary Falk
mi
from
Cleveland, OH
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Michael Grossman
mi
from
Oklahoma City, OK
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Michael Grossman
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Michael Mirhej, MD
mi
from
Eugene, OR
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Michael Mirhej, MD
mi
from
Eugene, OR
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Nayan Shah
mi
from
Eynon, PA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Nayan Shah
mi
from
Eynon, PA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Robert Fisher
mi
from
Philadelphia, PA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Robert Fisher
mi
from
Philadelphia, PA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Cynthia Strout
mi
from
Mount Pleasant, SC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Cynthia Strout
mi
from
Mount Pleasant, SC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Robert Smith, MD
mi
from
Saluda, SC
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Robert Smith, MD
mi
from
Saluda, SC
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Richard Krause
mi
from
Chattanooga, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Richard Krause
mi
from
Chattanooga, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Mark Swaim
mi
from
Jackson, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Mark Swaim
mi
from
Jackson, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
George James, MD
mi
from
Nashville, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
George James, MD
mi
from
Nashville, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Ronald Pruitt
mi
from
Nashville, TN
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Ronald Pruitt
mi
from
Nashville, TN
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. James Race
mi
from
Dallas, TX
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. James Race
mi
from
Dallas, TX
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Sardar Khan, MD
mi
from
Houston, TX
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Sardar Khan, MD
mi
from
Houston, TX
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Ralph Alhalel, MD
mi
from
McAllen, TX
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Ralph Alhalel, MD
mi
from
McAllen, TX
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Daniel Pambianco
mi
from
Charlottesville, VA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Daniel Pambianco
mi
from
Charlottesville, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Mark Ringold
mi
from
Christiansburg, VA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Mark Ringold
mi
from
Christiansburg, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Vinod Rustgi, MD
mi
from
Fairfax, VA
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Vinod Rustgi, MD
mi
from
Fairfax, VA
Click here to add this to my saved trials
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated:  1/8/2018
Dr. Michael Schmalz
mi
from
Milwaukee, WI
YM443 in Subjects With Functional Dyspepsia
A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia
Status: Enrolling
Updated: 1/8/2018
Dr. Michael Schmalz
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
Quality of Life in Barrett's Esophagus and GERD:GERD Symptoms, Perception of Cancer Risk, and Actual Cancer Risk
Status: Enrolling
Updated:  1/16/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease
Quality of Life in Barrett's Esophagus and GERD:GERD Symptoms, Perception of Cancer Risk, and Actual Cancer Risk
Status: Enrolling
Updated: 1/16/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated:  1/16/2018
Topeka VA Medical Center
mi
from
Topeka, KA
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated: 1/16/2018
Topeka VA Medical Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated:  1/16/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Impact of Weight Loss on Gastroesophageal Reflux Disease in Overweight and Obese Subjects: a Prospective Study
Status: Enrolling
Updated: 1/16/2018
Kansas City VA Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome
Status: Enrolling
Updated:  1/25/2018
Columbia University Medical Center
mi
from
New York, NY
Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal Microbiome
Pilot Randomized Trial to Assess the Effects of an Antimicrobial Mouthwash on the Esophageal and Gastric Microbiome
Status: Enrolling
Updated: 1/25/2018
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated:  2/5/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated: 2/5/2018
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated:  2/5/2018
The Mayo Clinic
mi
from
Rochester, MN
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Gastrointestinal Sensorimotor Dysfunctions in Diabetes Mellitus
Status: Enrolling
Updated: 2/5/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Status: Enrolling
Updated:  2/16/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Evaluation of Gastroesophageal Reflux in Patients on Continuous Positive Airway Pressure Ventilation for Obstructive Sleep Apnea
Status: Enrolling
Updated: 2/16/2018
Univ of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 1 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease
Status: Enrolling
Updated:  3/6/2018
University of Louisville
mi
from
Louisville, KY
A Phase 2 Study of Dexlansoprazole Delayed-Release Capsules to Treat Symptomatic Nonerosive Gastroesophageal Reflux Disease in Pediatric Subjects Aged 1 to 11 Years
A Phase 2, Double-Blind, 12 Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules in Pediatric Subjects Aged 1 to 11 Years With Symptomatic Nonerosive Gastroesophageal Reflux Disease
Status: Enrolling
Updated: 3/6/2018
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
University of Louisville
mi
from
Louisville, KY
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Johns Hopkins University School of Medicine
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Michigan Pediatric GI Center
mi
from
Flint, MI
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Michigan Pediatric GI Center
mi
from
Flint, MI
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
ProMedica Toledo Children's Hospital
mi
from
Toledo, OH
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
ProMedica Toledo Children's Hospital
mi
from
Toledo, OH
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Cook Children's Medical Center
mi
from
Fort Worth, TX
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Cook Children's Medical Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated:  3/23/2018
Hadassah University Hospital - Ein Kerem
mi
from
Jerusalem,
Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months
A Phase 1, Randomized, Open-Label, Parallel-Design, Multicenter Study to Evaluate the Pharmacokinetics, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Capsules in Infants Aged 1 to 11 Months With Acid-Related Diseases
Status: Enrolling
Updated: 3/23/2018
Hadassah University Hospital - Ein Kerem
mi
from
Jerusalem,
Click here to add this to my saved trials
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes
Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes
Status: Enrolling
Updated:  4/29/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Evaluating the Impact of Automated Evaluation of Gastrointestinal Symptoms (AEGIS) on Clinical Outcomes
Automated Evaluation of Gastrointestinal Symptoms (AEGIS): A Pragmatic Clinical Trial Evaluating the Impact of AEGIS on Clinical Outcomes
Status: Enrolling
Updated: 4/29/2018
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials